Dudediligence.

Structure Therapeutics Inc

GPCRNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

213.7M

on 2026-06-30, from 139.9M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

50M100M150M200MMar2024JunSepDecMar2025JunSepDec$65.00Mar2026Jun

Newest

No limit

S-3ASR of 2025-08-06. An automatic shelf: the form sets no dollar limit. 1 prospectus supplement filed under it since. S-3ASR ↗

$400.0M

Leerink Partners, agreement of 2026-05-07. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-06 is not read yet.

Cash

24.4 quarters

$1.34B on 2026-06-30 ÷ $55.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-12-10Public offeringnot read$65.00$650.0M424B5 ↗